NCT03385538View on ClinicalTrials.gov

Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

July 30, 2017

Study Completion Date

July 30, 2017

Conditions
Ischemic Stroke
Interventions
DRUG

Clopidogrel

increasing doses of clopidogrel depending on PRU values (75-300 mg)

Trial Locations (1)

4000

Zealand University Hospital, dept of neurology, Roskilde

All Listed Sponsors
lead

Zealand University Hospital

OTHER

NCT03385538 - Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients | Biotech Hunter | Biotech Hunter